Form 4: Maravai LifeSciences Exec's Tax Withholding

Maravai LifeSciences Holdings, Inc. Executive Vice President Christine Dolan disposed of 28,934 shares of Class A Common Stock to cover tax obligations related to restricted stock unit vesting.

Summary

• Christine Dolan, Executive Vice President & General Manager, Cygnus Technologies at Maravai LifeSciences Holdings, Inc. (MRVI), reported a transaction on January 15, 2026.
• Dolan disposed of 28,934 shares of Class A Common Stock at a price of $3.69 per share.
• This disposition was made to satisfy tax withholding obligations associated with the vesting of restricted stock unit awards.
• Following this transaction, Dolan directly beneficially owns 448,973 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The transaction is a routine tax withholding event for executive compensation, which is neutral in terms of company performance or outlook.

Future Outlook

NA

Industry Context

This is a routine insider transaction related to executive compensation and tax obligations, common across all industries for publicly traded companies when restricted stock units vest. It does not reflect broader industry trends or competitive positioning for Maravai LifeSciences.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine, non-discretionary transaction for tax purposes related to executive compensation.
• No direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Maravai LifeSciences, MRVI, Form 4, Insider Transaction, Stock Disposition, Tax Withholding, Restricted Stock Units, Christine Dolan, Executive Compensation